TY  - JOUR
T1  - Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
AU  - Blaha, V
AU  - Margoczy, R
AU  - Petrov, I
AU  - Postadzhiyan, A
AU  - Raslova, K
AU  - Rosolova, H
AU  - Bridges, I
AU  - Dhalwani, NN
AU  - Zachlederova, M
AU  - Ray, KK
DO  - 10.15420/ecr.2023.18.PO19
UR  - https://doi.org/10.15420/ecr.2023.18.PO19
JO  - European Cardiology Review 2023;18:e36.
Y1  - 2023
PB  - Radcliffe Cardiology
ER  -